Abstract
A REVIEW ON MEDICINAL PROPERTIES OF PSIDIUM GUAJAVA

Priyanka Pandey* and Wasim Raja

ABSTRACT

Guava is a tropical fruit native to South America. It belongs to the Myrtaceae family and is a well-liked plant. In contrast to other fruits, guava is untreated with chemicals, making it a healthier option. Nature has endowed Guava with many nutritional and medicinal properties. The fruits are 4-12 cm long with round or oval shape depending on the species (red, strawberry, and off-white). It has long been used as a homoeopathic herb to treat a variety of ailments throughout the globe. Oleanolic acid, tannins, quercetin, ursolic acid, triterpenes, pentacyclic triterpenoid, saponins, carotenoids, amritoside, guajanoic acid, lectins, leucocyanidin, beta-sitosterol and uvaol are among the active components. Guava contains antibacterial, anti-malarial, anti-diarrheal, antiinflammatory, anti-cancer, anti-hyperglycemic, and antioxidant properties, among others. Several studies have revealed that guava contains a number of pharmacological active components that are responsible for a variety of biochemical activities, including antidiabetic, antimicrobial, antidiarrheal, anti-oxidant, anti-pyretic, cardioactive, hepatoprotective, immunomodulatory, spasmolytic, and contractile effects, which are discussed further in the review. This article discusses about pharmacological activities and how they may be used to treat a variety of illnesses and diseases.

Keywords: Psidium guajava, anti-diarrheal, anti-hypertensive, anti-lipedema, anti-cancer, therapeutic benefits.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT